Allozymes
Business Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Cintech Iv 79 Science Park Dr #06-05, Si...Website
www.allozymes.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Allozymes
Allozymes is a biotechnology company focused on enzyme discovery and engineering, utilizing advanced microfluidics technology to create sustainable biosolutions across various industries. Their services cater to pharmaceuticals, life sciences, food and nutrition, chemicals, bioremediation, and personal care sectors, aiming to reduce environmental impact and enhance efficiency. The company offers partnership models including enzyme engineering services and biosolutions licensing to support clients in achieving their sustainability goals. With a commitment to innovation, Allozymes is dedicated to transforming traditional methods into more sustainable alternatives, thereby contributing to a healthier planet.Explore more
Allozymes Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allozymes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Allozymes
Earning: See what the market has to say on Allozymes recently announced quarterly report
Funding: Get notified immidiatlly once Allozymes has new funding data
Product Launch: Get notified when Allozymes launches new products
Click to see if Allozymes had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Allozymes has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Allozymes is spiking on competitors!
Allozymes, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Allozymes is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Allozymes is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Allozymes.
Allozymes financials insights
Gather financial insights about Allozymes, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$5M
2024
Series A
$15M
Allozymes Tech Stack
A closer look at the technologies used by Allozymes
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Open Position
Funding
Open Position
Partnership
Partnership
Allozymes News & Media
Allozymes and Bonumose Collaborate to Accelerate Enzyme Innovations for Beneficial Food & Supplement Ingredients
SINGAPORE, March 31, 2025 /PRNewswire/ -- Allozymes, a leader in protein engineering, and Bonumose, a leader in innovative enzyme combinations enabling the production of high-volume, healthy, naturally occurring monosaccharides from commodity feedstocks such as starch and sugar, announce...Allozymes and Adisseo Partner on Next-Gen Animal Feed Production Using Rapid Microfluidics Technology
SINGAPORE, Aug. 19, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announces a strategic partnership with Adisseo, one of the world's leading animal nutrition companies, to develop groundbreaking bioprocesses for animal feed ingredient...Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions
SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore. This significant investment underscores the growing recognition of Allozymes' transformative potential, accelerates its expansion into Europe, and forges strategic partnerships within the food and chemical industries while paving the way for new partnersAllozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M
Allozymes uses a method in which millions of enzymes can be tested per day, rather than just a few hundred. © 2024 TechCrunch. All rights reserved. For personal use only.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Allozymes
Sign Up For FreeTo access detailed company insights
Allozymes is a biotechnology company focused on enzyme discovery and engineering, utilizing advanced microfluidics technology to create sustainable biosolutions across various industries. Their services cater to pharmaceuticals, life sciences, food and nutrition, chemicals, bioremediation, and personal care sectors, aiming to reduce environmental i... Read More
